1. Soares de Oliveira C, Lira BF, Barbosa-Filho JM, Lorenzo JGF, Filgueiras de Athayde-Filho P (2012) Synthetic approaches and pharmacological activity of 1,3,4-Oxadiazoles: a review of the literature from 2000–2012. Molecules 17:10192–10231
2. Chauviere G, Bouteille B, Enanga B, Croft SL, Dumas M, Perie J, de Albuquergue C (2003) Synthesis and biological activity of nitro heterocycles analogous to megazol, a trypanocidal lead. J Med Chem 46:427–440
3. Mazzone G, Bonina F, Pulglisi G, Panico AM, Arrigo RR (1984) 2,5-Diaryl-substituted 1,3,4-oxadiazoles: synthesis and preliminary pharmacological investigation. Farmaco Ed Sci 39:414–420
4. Raman K, Parmar SS, Salzman SK (1989) Anti-inflammatory activity of substituted 1,3,4-oxadiazoles. J Pharm Sci 78:999–1002
5. Ergenc N, Buyuktimkin S, Capan G, Baktir G, Rollas S (1991) Quinazolinones. 19. Communication [1]: synthesis and evaluation of some CNS depressant properties of 3-(2-[(5-aryl-1,3,4-oxadiazole-2-yl)amino]acetamido)-2-methyl-4(3H)-quinazolinones. Pharmazie 46:290–291